United Therapeutics Investor Relations Material
Latest events
Q1 2025
United Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from United Therapeutics Corporation
Access all reports
United Therapeutics Corporation is a biotechnology company specializing in the development and commercialization of therapies to address chronic and life-threatening conditions. The company focuses on treatments for pulmonary arterial hypertension (PAH) and other cardiovascular and respiratory diseases. Its portfolio includes pharmaceutical products and delivery systems designed to improve patient outcomes and quality of life. The company is headquartered in Silver Spring, Maryland, and its shares are listed on the NASDAQ Stock Exchange.
Key slides for United Therapeutics Corporation
Q3 2024
United Therapeutics Corporation
Q1 2025
United Therapeutics Corporation
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
UTHR
Country
🇺🇸 United States